Cucurbitacine

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 16.04.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Group of tetracyclic, steroidal bitter compounds(triterpene), which are usually present in plants in glycosidic form. Cucurbitacins are heat-resistant, hardly water-soluble substances; they are thus preserved when vegetables are cooked.

OccurrenceThis section has been translated automatically.

Cucurbitacins are mainly found in cucumbers (Cucumis) and pumpkin plants(Cucurbitaceae), in some cruciferous plants (Brassicaceae) as well as in the Japanese basidiomycetes Hebeloma vinosophyllum. Around 200 derivatives of cucurbitacins are known.

EffectsThis section has been translated automatically.

Cucurbitacins have a strong laxative, diuretic, antihypertensive, antirheumatic and antiproliferative (experimental) effect. All cucurbitacins are toxic in appropriate concentrations.

They have insecticidal and antimycotic effects. Of great scientific interest is their antiproliferative effect, which has been experimentally proven in numerous tumour cell lines (chondrosarcoma, melanoma, bonchial carcinoma, colon carcinoma). Cucurbitacins inhibit the JAK-STAT3 and MAPK signalling pathways, which play a central role in apoptosis and survival of tumour cells. They also inhibit the migration and invasiveness of tumour cells.

LiteratureThis section has been translated automatically.

  1. Abbas S et al.(2013) The cucurbitacins E, D and I: investigation of their cytotoxicity toward human chondrosarcoma SW 1353 cell line and their biotransformation in man liver. Toxicol Lett 216(2-3):189-199.
  2. Cai Y et al. (2015) Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity. Am J Chin Med 43:1331-1350.
  3. Chawech R et al. (2015) Cucurbitacins from the Leaves of Citrullus colocynthis (L.) Schrad. Molecules 20:18001-18015.
  4. Chen X et al. (2012) Biological activities and potential molecular targets of cucurbitacins: a focus on cancer. Anticancer Drugs 23:777-787.
  5. Guo J et al. (2015) The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained release carriers: in situ-forming implants. AAPS PharmSciTech 16:973-985.
  6. Silva IT et al. (2016) Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549. Invest New Drugs 34:139-148.
  7. Wang Y et al. (2014) Cucurbitacin IIb exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes.PLoS One 9:e89751.

Authors

Last updated on: 16.04.2024